Dr. Schär” ‐ the world’s leading nutrition and gluten-free brand ‐ appoints new CEO as it seeks to accelerate its global expansion

‘Dr. Schär’, the special nutrition and gluten-free global leader has appointed Hannes Berger as their new CEO, tasking him with accelerating the expansion of the business globally.

 The former CEO, Philipp Schoeller, has resigned from his position as CEO at his own request at the end of 2022. Mr. Schoeller had taken on the role in 2020.

 Philipp Schoeller: “I am grateful to Ulrich Ladurner, President of Dr. Schär, for the trust in me and now the support for my decision. I would especially like to thank my colleagues at Dr. Schär, with whom I worked closely and in a spirit of trust. We can all be proud of the new growth we have created together and the success in strengthening the Schär brand. With great enthusiasm and passion, I have led our global business as the market leader for gluten-free nutrition.”

Ulrich Ladurner, has commented: “I would like to thank Philipp Schoeller for the successful collaboration – his outstanding achievements and his dedicated work. He has kept Dr. Schär going in these difficult times, strengthened our global presence and boosted innovation. I hold Mr. Schoeller in high esteem, regret his departure and wish him all the best and continued success in his future career and life. With the departure of Philipp Schoeller, we want to continue the path we have taken with someone at the top who has known the company well for almost two decades and decisively shaped it in a leading position during this time. We are pleased that Hannes Berger will take over the CEO role at Dr. Schär and we are sure that the company will be in excellent and experienced hands.” 

Hannes Berger has held key positions in the company for almost two decades and is a member if the Board of Directors since its establishment. In the past five years he has been focused on the development of the overseas markets as CEO and President of North America and then expanding his responsibilities also to Latin America, UK and Ireland. Under his leadership, US sales have more than doubled to become one of the Company’s key markets supported by continuous investment in the expansion of the local production sites.

Dr. Schär will be exceeding 500 million euros in revenues this year and wants to further accelerate the business by expanding into new geographies and into new nutritional categories. Hannes Berger has commented on the new role: “I would like to thank Ulrich Ladurner for the trust he has placed in me and look forward to working with the entire team to achieve the ambitious goals we have set ourselves.”

  • bitcoinBitcoin (BTC) $ 95,679.00 2.91%
  • ethereumEthereum (ETH) $ 3,346.58 4.06%
  • tetherTether (USDT) $ 0.999185 0.08%
  • xrpXRP (XRP) $ 2.16 5.57%
  • bnbBNB (BNB) $ 690.28 2.61%
  • solanaSolana (SOL) $ 188.48 4.98%
  • usd-coinUSDC (USDC) $ 1.00 0.08%
  • staked-etherLido Staked Ether (STETH) $ 3,346.10 4.01%
  • cardanoCardano (ADA) $ 0.867691 5.52%
  • tronTRON (TRX) $ 0.251814 2.04%
  • avalanche-2Avalanche (AVAX) $ 37.70 7.29%
  • the-open-networkToncoin (TON) $ 5.75 5.42%